Filippo Emanuele Colella

Filippo Emanuele Colella

Auto-generated profile, based on publicly available information

Filippo Emanuele Colella

Department of Biomedical Sciences, Humanitas University, Milan, Italy

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 May 2026 in Journal Of Neuroradiology
Verified
Journal Article
Closed access
LCLeonardo Di Cosmo
Leonardo Di Cosmo
FCFilippo Emanuele Colella
Filippo Emanuele Colella
PŁPaweł Łajczak
Paweł Łajczak
ESEdoardo Schifino
Edoardo Schifino
SCSantiago Nieto Cuervo
Santiago Nieto Cuervo
BSBruno Fernandes de Oliveira Santos
Bruno Fernandes de Oliveira Santos

29 June 2026 in World Neurosurgery
Verified
Journal Article
Open access
Matteo ScaliseMatteo Scalise
Matteo Scalise
DPDomenico Pontillo
Domenico Pontillo
CCCarlo Cossa
Carlo Cossa
FCFilippo Emanuele Colella
Filippo Emanuele Colella
GEGiuseppe Esposito
Giuseppe Esposito
DCDelia Cannizzaro
Delia Cannizzaro
Multiple intracranial aneurysms (MIAs) represent a clinically challenging subset of intracranial aneurysms, with uncertainty persisting regarding optimal management strategies. In particular, whether aneurysms should be treated in a single-stage or multi-stage approach remains unresolved. This meta-analysis aimed to compare clinical and radiological outcomes between these two strategies. A systematic review was conducted according to PRISMA guidelines and registered in PROSPERO (CRD420251066054). PubMed/MEDLINE, Web of Science, Scopus, and EMBASE were searched from January 2000 to May 2026. Studies reporting outcomes of adult patients with MIAs managed using single or multi-stage strategies were included. The primary endpoint was the incidence of major complications. Secondary endpoints comprised clinical outcomes, ischemic and hemorrhagic complications. Pooled risk ratios (RRs) with 95% confidence intervals (CIs) were calculated using random-effects models. Eight studies were included, with five eligible for quantitative synthesis. No significant differences were observed between single-stage and multi-stage strategies regarding major (RR 0.85, 95% CI: 0.46-1.59; p = 0.617), hemorrhagic (RR 0.50, 95% CI: 0.15-1.72; p = 0.273), or ischemic complications (RR 1.14, 95% CI: 0.85-1.53; p = 0.373), or in favorable (RR 1.00, 95% CI: 0.96-1.03; p = 0.870) or poor clinical outcomes (RR 1.09, 95% CI: 0.29-4.09; p = 0.893). Single-stage and multi-stage treatment strategies for MIAs demonstrate comparable safety and efficacy profiles. Treatment selection should therefore be individualized based on aneurysm characteristics, patient condition, and institutional expertise rather than an expected difference in outcomes. Prospective studies with standardized reporting are needed to further refine optimal management strategies.

22 December 2025 in Clinical Neurophysiology
Verified
Journal Article
Closed access
WTWilliam O. Tatum
William O. Tatum
ASAdrian Safa
Adrian Safa
FCFilippo Colella
Filippo Colella
EMErik H. Middlebrooks
Erik H. Middlebrooks
AFAnteneh M. Feyissa
Anteneh M. Feyissa
BFBrin Freund
Brin Freund

3 August 2026 in Journal of Neurosurgery: Case Lessons
Verified
Journal Article
Open access
PDF file
BFBrin E. Freund
Brin E. Freund
VVVenkateshwaran Vijayanarasimhan
Venkateshwaran Vijayanarasimhan
ASAdrian Safa
Adrian Safa
JEJustyna Ekert
Justyna Ekert
FCFilippo Emmanuele Colella
Filippo Emmanuele Colella
WTWilliam O. Tatum
William O. Tatum
BACKGROUND: The authors aimed to evaluate the feasibility/safety of stereo-electroencephalography (SEEG) and SEEG-guided radiofrequency thermocoagulation (RFTC) in patients with drug-resistant epilepsy previously implanted with neuromodulation devices, using a retrospective cohort design evaluating patients treated at the Mayo Clinic Florida Epilepsy Center. OBSERVATIONS: Nine patients (mean age 36.3 ± 10.9 years, 33% female) with prior implantation of neuromodulation devices were included. A vagus nerve stimulator was present in 8 of 9 patients, and 4 patients had undergone previous intracranial neuromodulation. Five patients underwent SEEG-RFTC. The mean SEEG monitoring duration was 6.5 ± 2.9 days. No intraoperative or procedural complications occurred, including hardware-related issues. No permanent or significant neurological/cognitive deficits occurred. One patient experienced transient postoperative neurological symptoms attributed to perilesional edema. Seizure reduction ranged from 50% to 75% following SEEG-RFTC. LESSONS: SEEG and SEEG-RFTC are feasible in patients who have implanted neuromodulation devices, including intracranial implants. These procedures may be performed without interference with existing hardware and provide meaningful seizure reduction in highly refractory populations. Further studies with larger cohorts and longer follow-up are needed to better define efficacy and patient selection. https://thejns.org/doi/10.3171/CASE26376

17 December 2025 in Clinical Neurophysiology
Verified
Journal Article
Closed access
BFBrin E. Freund
Brin E. Freund
ASAdrian Safa
Adrian Safa
FCFilippo Emanuele Colella
Filippo Emanuele Colella
GCGuido Chiriboga
Guido Chiriboga
TBToni Betiku
Toni Betiku
WTWilliam O. Tatum
William O. Tatum

20 June 2026 in bioRxiv
Verified
Preprint
Open access
GGGiulia Grion
Giulia Grion
RHRashid Hussain
Rashid Hussain
FCFilippo Emanuele Colella
Filippo Emanuele Colella
KRKirollos Roufail
Kirollos Roufail
SUSilvia Uccella
Silvia Uccella
SRSalvatore Lorenzo Renne
Salvatore Lorenzo Renne
Quantifying vascular architecture in histological whole slide images is needed to study tissue organisation, tumour microenvironment biology, and diseaseassociated vascular remodelling. However, vessel analysis in routine immunohistochemistry remains challenging. Available workflows are often manual, require programming expertise, or lack direct integration with digital pathology platforms. We developed VeSpA (Vessel Spatial Analysis), an open-source pipeline and QuPath extension for automated vessel segmentation and morphometric quantification in CD31-stained whole slide images. VeSpA combines configurable signal extraction, using CMYK Yellow channel extraction by default and optional DAB stain deconvolution for H-DAB images, with automatic or percentile-based thresholding, morphological refinement, contour filtering, and lumen filling to generate vessel masks from standard DAB-stained sections. The QuPath extension includes a graphical interface for selecting annotations, TMA cores, or whole images, configuring segmentation parameters, running the Python backend, and importing vessel objects directly into the QuPath hierarchy. For each detected vessel, VeSpA extracts area, major axis length, minor axis length, eccentricity, centroid, and orientation, while also appending summary measurements to parent annotations and TMA cores. Validation against independent pathologist annotations showed that VeSpA achieved segmentation performance close to inter-rater agreement and outperformed yellow channel prompt-based SAM and zero-shot YOLOv8-seg on overlap-based metrics in the tested dataset. VeSpA integrates vessel segmentation, morphometric feature extraction, and QuPath-based visualisation into a single reproducible workflow for vascular quantification in computational pathology and spatial analysis of histological tissue architecture.